Skip to content

Effect of Guided Imagery and Progressive Muscle Relaxation as a Means to Improve the Psychological Well-being and the Quality of Life for Patients With Breast and Prostate Cancer

A Randomized Clinical Trial on the Effect of Guided Imagery and Progressive Muscle Relaxation for the Management of Pain, Stress, Anxiety and Depression as a Means to Improve the Psychological Well-being and the Quality of Life for Patients With Breast and Prostate Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01275872
Enrollment
200
Registered
2011-01-13
Start date
2010-04-30
Completion date
2011-10-31
Last updated
2011-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Prostate Cancer

Keywords

guided imagery, progressive muscle relaxation, complimentary and alternative medicine, quality of life, stress, pain, anxiety

Brief summary

The purpose of this study is to determine whether Guided Imagery and Progressive Muscle Relaxation techniques are effective in the management of pain, fatigue, nausea-vomit, anxiety and depression in patients with either prostate or breast cancer. This study includes a total of 200 patients with prostate and breast cancer randomly assigned to either a control or intervention group. The intervention group received in total 4 sessions of Guided Imagery (protocol floating on a cloud) and Progressive Muscle Relaxation (breathing exercises and use of 11 groups of muscle progressively tensing and relaxing). Measurements included the assessment of pain, fatigue, nausea-vomit, depression, anxiety and quality of life. Additionally, saliva samples were collected prior and after the sessions as to assess saliva cortisol and saliva α-amylase. The same measurements were received by the patients of the control group as to allow comparisons.

Interventions

4 supervised sessions per patient for 4 weeks additional to daily unsupervised sessions

Sponsors

Cyprus University of Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 72 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of breast or prostate cancer * Must be able to follow instructions * Good cognitive ability * Willing to participate

Exclusion criteria

* Use of cortisone * Xerostomia * oral mucositis

Design outcomes

Primary

MeasureTime frameDescription
Stress20 monthsSaliva α-amylase and saliva cortisol

Secondary

MeasureTime frame
Fatigue20 months
Anxiety20 months
Quality of Life20 months
Nausea-vomit20 months
Pain20 months
Depression20 months

Countries

Cyprus

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026